GAPDHP37

Across TCGA pan-cancer cohorts, GAPDHP37 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated GAPDHP37 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher GAPDHP37 RNA is associated with better overall survival. In most high-consensus cancer types, elevated GAPDHP37 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCEC show a favorable association.

BRCA, MESO, and KICH are the cancer types where GAPDHP37 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.973	0.951	.001	38	view →
MESO	OS	Tertile	II,III,IV	0.228	0.603	.016	36	view →
KICH	DFS	Tertile	III,IV	0.100	0.737	.012	36	view →
UCEC	DFS	Median	II,III,IV	0.734	0.260	.002	32	view →
DLBC	DFS	Median	III,IV	0.318	0.885	.010	27	view →
UVM	DFS	Quartile	II,III,IV	0.198	0.736	<.001	26	view →
THYM	OS	Median	All	1.000	0.704	<.001	23	view →
KIRP	DFS	Median	All	0.980	0.793	.005	21	view →
OV	OS	Median	II,III,IV	0.815	0.867	.017	12	view →
BLCA	OS	Tertile	III,IV	0.639	0.500	.026	9	view →
LIHC	OS	Tertile	III,IV	0.765	0.247	.018	9	view →
CESC	DFS	Median	All	0.628	0.470	.017	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

GAPDHP37–BRCA (OS)

Open the BRCA breakdown →